USPTO trademark

KORVOZIO

RegisteredUSPTOWord markClass 5

"KORVOZIO" is a word mark owned by Glaxo Group Limited, filed at the USPTO on September 10, 2021. It is registered and covers class 5 (Pharmaceuticals).

View Glaxo Group Limited portfolioGet this data via the API
Official USPTO record
KORVOZIO trademark as filed
As filed with the USPTO
Status
Registered
Since October 11, 2022
Filed
September 10, 2021
Registered
October 11, 2022
Priority date
April 19, 2021
Claimed from United Kingdom
Application no.
97021940
Registration no.
6870304
Office
USPTO
United States Patent and Trademark Office
Mark type
Word mark
1 class
Ownership

Who owns KORVOZIO

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

Glaxo Group Limited

Stevenage, United Kingdom

19,383 trademarks in the portfolioView company

Representative

Elizabeth K. Rucki

GlaxoSmithKline

Goods and services

What the mark covers

The products and services KORVOZIO is filed for, grouped by Nice class.

  • (Based on 44(d) Priority Application) Vaccines; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders(Based on 44(e)) Vaccines; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Teas change of correspondence received
  2. Attorney/dom.rep.revoked and/or appointed
  3. Teas revoke/app/change addr of atty/dom rep received
  4. Applicant/correspondence changes (non-responsive) entered
  5. Teas change of owner address received
  6. Applicant/correspondence changes (non-responsive) entered
  7. Teas change of correspondence received
  8. Attorney/dom.rep.revoked and/or appointed
  9. Teas revoke/app/change addr of atty/dom rep received
  10. Teas change of owner address received

10 earlier steps on the official record.

FAQ

About KORVOZIO

Who owns the trademark "KORVOZIO"?

The USPTO trademark "KORVOZIO" (application 97021940) is owned by Glaxo Group Limited.

What is the status of "KORVOZIO"?

Its status at the USPTO is: registered.

When was "KORVOZIO" registered?

It was registered on October 11, 2022.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull KORVOZIO and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_019d2dae-c4d5-715f-9233-1e6085eb7c8d
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019d2dae-c4d5-715f-9233-1e6085eb7c8d",
  "object": "trademark",
  "mark_text": "KORVOZIO",
  "status": {
    "primary": "active",
    "stage": "registered"
  },
  "office_code": "US",
  "application_number": "97021940",
  "filing_date": "2021-09-10",
  "nice_classes": [
    5
  ],
  "owners": [
    {
      "name": "Glaxo Group Limited",
      "entity_id": "ent_019eb6f6-4cb9-77ae-916f-63b3231a6d3d"
    }
  ]
}